The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors

Published:2016-12 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Chantalat Elodie,Boudou Frédéric,Laurell Henrik,Palierne Gaëlle,Houtman René,Melchers Diana,Rochaix Philippe,Filleron Thomas,Stella Alexandre,Burlet-Schiltz Odile,Brouchet Anne,Flouriot Gilles,Métivier Raphaël,Arnal Jean-François,Fontaine Coralie,Lenfant Françoise^ORCID

Funder

Agence Nationale de la Recherche

Ligue Contre le Cancer

Conseil Regional Midi-Pyrénées

Fondation pour la Recherche Médicale

CHU Rangueil

European Funds

Fondation de France (FR)

CNRS-Université de Rennes 1

Association pour la Recherche sur le Cancer

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0780-7.pdf

Reference52 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

2. Johnston SR. New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res. 2010;16(7):1979–87.

3. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333(22):1456–61.

4. Howell A. Adjuvant aromatase inhibitors for breast cancer. Lancet. 2005;366(9484):431–3.

5. Silvestrini R, Daidone MG, Luisi A, Boracchi P, Mezzetti M, Di Fronzo G, Andreola S, Salvadori B, Veronesi U. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J Clin Oncol. 1995;13(3):697–704.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Impact of Aberrant Splicing Machinery on Drug Resistance in Breast Cancer: Identifying Targets for Innovative Counteractive Strategies;Overcoming Breast Cancer Therapy Resistance;2024

2. Alternative promoters and splicing create multiple functionally distinct isoforms of oestrogen receptor alpha in breast cancer and healthy tissues;Cancer Medicine;2023-09

3. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway;Phytomedicine;2023-09

4. Progress in the Understanding of Estrogen Receptor Alpha Signaling in Triple-Negative Breast Cancer: Reactivation of Silenced ER-α and Signaling through ER-α36;Molecular Cancer Research;2023-08-02

5. In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers;International Journal of Molecular Sciences;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3